These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 35474598)
21. Temporal profile of serum neurofilament light in multiple sclerosis: Implications for patient monitoring. Calabresi PA; Arnold DL; Sangurdekar D; Singh CM; Altincatal A; de Moor C; Engle B; Goyal J; Deykin A; Szak S; Kieseier BC; Rudick RA; Plavina T Mult Scler; 2021 Sep; 27(10):1497-1505. PubMed ID: 33307998 [TBL] [Abstract][Full Text] [Related]
22. Serum neurofilament levels in patients with multiple sclerosis: A comparison of SIMOA and high sensitivity ELISA assays and contributing factors to ELISA levels. Revendova KZ; Zeman D; Bunganic R; Karasova K; Volny O; Bar M; Kusnierova P Mult Scler Relat Disord; 2022 Nov; 67():104177. PubMed ID: 36130459 [TBL] [Abstract][Full Text] [Related]
23. Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study. Bittner S; Steffen F; Uphaus T; Muthuraman M; Fleischer V; Salmen A; Luessi F; Berthele A; Klotz L; Meuth SG; Bayas A; Paul F; Hartung HP; Linker R; Heesen C; Stangel M; Wildemann B; Then Bergh F; Tackenberg B; Kuempfel T; Weber F; Zettl UK; Ziemann U; Tumani H; Groppa S; Mühlau M; Lukas C; Hemmer B; Wiendl H; Gold R; Zipp F; EBioMedicine; 2020 Jun; 56():102807. PubMed ID: 32460167 [TBL] [Abstract][Full Text] [Related]
25. Temporal association of sNfL and gad-enhancing lesions in multiple sclerosis. Rosso M; Gonzalez CT; Healy BC; Saxena S; Paul A; Bjornevik K; Kuhle J; Benkert P; Leppert D; Guttmann C; Bakshi R; Weiner HL; Chitnis T Ann Clin Transl Neurol; 2020 Jun; 7(6):945-955. PubMed ID: 32452160 [TBL] [Abstract][Full Text] [Related]
26. Serum neurofilament light chain levels in healthy individuals: A proposal of cut-off values for use in multiple sclerosis clinical practice. Valentino P; Marnetto F; Martire S; Malucchi S; Bava CI; Popovic M; Bertolotto A Mult Scler Relat Disord; 2021 Sep; 54():103090. PubMed ID: 34182224 [TBL] [Abstract][Full Text] [Related]
27. Serum neurofilament light chain correlates with myelin and axonal magnetic resonance imaging markers in multiple sclerosis. Yik JT; Becquart P; Gill J; Petkau J; Traboulsee A; Carruthers R; Kolind SH; Devonshire V; Sayao AL; Schabas A; Tam R; Moore GRW; Li DKB; Stukas S; Wellington C; Quandt JA; Vavasour IM; Laule C Mult Scler Relat Disord; 2022 Jan; 57():103366. PubMed ID: 35158472 [TBL] [Abstract][Full Text] [Related]
28. Intermediate-Intensity Autologous Hematopoietic Stem Cell Transplantation Reduces Serum Neurofilament Light Chains and Brain Atrophy in Aggressive Multiple Sclerosis. Mariottini A; Marchi L; Innocenti C; Di Cristinzi M; Pasca M; Filippini S; Barilaro A; Mechi C; Fani A; Mazzanti B; Biagioli T; Materozzi F; Saccardi R; Massacesi L; Repice AM Front Neurol; 2022; 13():820256. PubMed ID: 35280289 [TBL] [Abstract][Full Text] [Related]
29. Longitudinal serum neurofilament light chain (sNfL) concentration relates to cognitive function in multiple sclerosis patients. Mattioli F; Bellomi F; Stampatori C; Mariotto S; Ferrari S; Monaco S; Mancinelli C; Capra R J Neurol; 2020 Aug; 267(8):2245-2251. PubMed ID: 32296939 [TBL] [Abstract][Full Text] [Related]
30. Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis. Maggi P; Kuhle J; Schädelin S; van der Meer F; Weigel M; Galbusera R; Mathias A; Lu PJ; Rahmanzadeh R; Benkert P; La Rosa F; Bach Cuadra M; Sati P; Théaudin M; Pot C; van Pesch V; Leppert D; Stadelmann C; Kappos L; Du Pasquier R; Reich DS; Absinta M; Granziera C Neurology; 2021 Aug; 97(6):e543-e553. PubMed ID: 34088875 [TBL] [Abstract][Full Text] [Related]
31. MRI Lesion State Modulates the Relationship Between Serum Neurofilament Light and Age in Multiple Sclerosis. Rosso M; Healy BC; Saxena S; Paul A; Bjornevik K; Kuhle J; Benkert P; Leppert D; Guttmann C; Bakshi R; Weiner HL; Chitnis T J Neuroimaging; 2021 Mar; 31(2):388-393. PubMed ID: 33476489 [TBL] [Abstract][Full Text] [Related]
32. A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis. Tavazzi E; Bergsland N; Kuhle J; Jakimovski D; Ramanathan M; Maceski AM; Tomic D; Hagemeier J; Kropshofer H; Leppert D; Dwyer MG; Weinstock-Guttman B; Benedict RHB; Zivadinov R J Neurol; 2020 Mar; 267(3):802-811. PubMed ID: 31768628 [TBL] [Abstract][Full Text] [Related]